Blade Air Mobility, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Robert S. Wiesenthal
- Full Time Employees
- 310
- Sector
- Industrials
- Industry
- Airlines, Airports & Air Services
- Address
- 499 East 34th Street New York City NY United States of America 10016
- IPO Date
- Nov 5, 2019
- CIK
- 0001779128
- Website
- blade.com
- Similar Companies
- Business
- Blade Air Mobility, Inc. (BLDE) operates as a technology-powered urban air mobility platform, providing short-distance passenger flights via helicopters and amphibious seaplanes; jet charters and ground transportation; and medical logistics including organ transport for transplants, donor coordination, and surgical recovery services under brands such as MediMobility and Trinity Medical Solutions. The company serves passengers on routes primarily in the Northeast United States, Southern Europe, Canada, and India, alongside hospitals and organ procurement organizations across the United States and internationally; it maintains dedicated terminals in key markets like New York and offers app-based seat bookings, full charters, and crowdsourced flights. Founded in 2014 and headquartered at 31 Hudson Yards in New York City, Blade employs approximately 310 people and focuses on reducing travel friction through cost-effective aviation alternatives in the passenger and medical segments. In August 2025, Blade completed the sale of its passenger division to Joby Aviation, Inc. for up to $125 million in cash or stock, retaining its medical logistics operations as an independent public entity and rebranding to Strata Critical Medical, Inc. with a new ticker symbol SRTA. The transaction excludes the organ transplant business, which continues under Strata with planned collaboration on medical transportation services with Joby, while providing Blade immediate market access, infrastructure, and customer base integration for Joby's electric air taxi rollout. This strategic divestiture marks a major operational shift, positioning the remaining entity as a specialized provider of time-critical healthcare logistics including air and ground transport, normothermic regional perfusion, and perfusion staffing solutions.
Strata Announces 2025 Investor Day
Strata Acquires Keystone Perfusion, Creating Integrated Organ Recovery Platform, Diversifying into Other Medical Services
Strata Critical Medical to Present at the 2025 Jefferies Industrials Conference
Blade Air Mobility Sets Timing for Name Change to Strata Critical Medical and Commencement of Trading Under the New Ticker Symbol “SRTA”
Is Joby Aviation Stock a Buy?
Blade Air Mobility to Present at the Oppenheimer 28th Annual Technology, Internet & Communications Conference
Joby Deal Gives Blade New Direction, But Stock Lacks Lift
Blade (BLDE) Q2 Revenue Jumps 10%
Blade Air Mobility: Disappointing Exit
Blade Air Mobility, Inc. (BLDE) Q2 2025 Earnings Call Transcript
Blade Air Mobility, Inc. (BLDE) Reports Q2 Loss, Tops Revenue Estimates
Blade Air Mobility Announces Second Quarter 2025 Results
Our Trade On Joby Aviation
Joby Stock Takes Flight After Deal With Blade Air Mobility
Joby Aviation: Why Acquiring Blade Air Mobility Makes Sense
Joby Aviation to buy Blade Air Mobility's ride-share business
Blade announces sale of Passenger Division to Joby, Transitions to Pure-Play Medical Services and Logistics Business
Blade Air Mobility Announces Date for Second Quarter Ending June 30, 2025 Earnings Release Conference Call
Blade Air Mobility: Waiting For eVTOLs
Here's Why Blade Air Mobility, Inc. (BLDE) is a Great Momentum Stock to Buy